Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
Phase of Trial: Phase IV
Latest Information Update: 27 May 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 22 May 2017 Status changed from not yet recruiting to recruiting.
- 12 May 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jun 2017.
- 14 Feb 2017 New trial record